IFNA1 and infection: In an investigator-initiated open-label study, human recombinant IFNα nasal drops seemed to effectively prevent infection in medical personnel who were likely to be exposed to SARS-CoV-2, indicating that IFNα inhalation has promise for protecting susceptible healthy people during the coronavirus pandemic, and underlining the importance of IFN in this disease [30].